LEADER 01670nam0 2200373 i 450 001 SUN0124569 005 20191022111810.66 010 $d0.00 017 70$2N$a978-3-030-00641-9 100 $a20191021d2018 |0engc50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aAn *Introduction to the Language of Mathematics$fFrédéric Mynard 205 $aCham : Springer, 2018 210 $axii$d185 p.$cill. ; 24 cm 215 $aPubblicazione in formato elettronico 606 $a11Axx$xElementary number theory [MSC 2020]$2MF$3SUNC019694 606 $a03E25$xAxiom of choice and related propositions [MSC 2020]$2MF$3SUNC020025 606 $a06A06$xPartial order, general [MSC 2020]$2MF$3SUNC022498 606 $a11A51$xFactorization; primality [MSC 2020]$2MF$3SUNC023242 606 $a03E20$xOther classical set theory (including functions, relations, and set algebra) [MSC 2020]$2MF$3SUNC024408 606 $a03Bxx$xGeneral logic [MSC 2020]$2MF$3SUNC024425 606 $a03F07$xStructure of proofs [MSC 2020]$2MF$3SUNC031517 606 $a97Exx$xEducation of foundations of mathematics [MSC 2020]$2MF$3SUNC034147 620 $aCH$dCham$3SUNL001889 700 1$aMynard$b, Frédéric$3SUNV057364$0732154 712 $aSpringer$3SUNV000178$4650 801 $aIT$bSOL$c20210503$gRICA 856 4 $uhttp://doi.org/10.1007/978-3-030-00641-9 912 $aSUN0124569 950 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08CONS e-book 1031 $e08eMF1031 20191021 996 $aIntroduction to the Language of Mathematics$91564654 997 $aUNICAMPANIA LEADER 02217nam 2200577 450 001 9910827838803321 005 20230803021102.0 010 $a1-78084-270-8 010 $a1-78084-271-6 035 $a(CKB)2550000001101935 035 $a(EBL)1179645 035 $a(OCoLC)854971660 035 $a(SSID)ssj0001599928 035 $a(PQKBManifestationID)16306258 035 $a(PQKBTitleCode)TC0001599928 035 $a(PQKBWorkID)14892839 035 $a(PQKB)11287715 035 $a(MiAaPQ)EBC1179645 035 $a(Au-PeEL)EBL1179645 035 $a(EXLCZ)992550000001101935 100 $a20220517d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEmerging therapeutic options for hepatitis C /$feditors, Masao Omata, Tatsuo Kanda 205 $a1st ed. 210 1$aLondon, England :$cFuture Medicine Ltd.,$d[2013] 210 4$d©2013 215 $a1 online resource (117 p.) 300 $aDescription based upon print version of record. 311 $a1-78084-272-4 327 $aTitle page; Copyright page; Contents; Foreword. Hepatitis C virus infection: from discovery to eradication; 1. Interferons in clinical trials; 2. Protease inhibitors; 3. NS5A inhibitor: daclatasvir; 4. Toll-like receptor agonists for nonresponders to hepatitis C virus treatment: hope versus promise?; 5. Treatment options in HIV-HCV-coinfected patients; 6. Treatment options for dual hepatitis C/hepatitis B virus coinfection; 7. Hepatitis C virus treatment in patients with metabolic syndrome; 8. Future directions in hepatitis C therapy; Index 330 $aEmerging Therapeutic Options for Hepatitis C 606 $aHepatitis C$xTreatment 606 $aHepatitis C$xChemotherapy 606 $aAntiviral agents 615 0$aHepatitis C$xTreatment. 615 0$aHepatitis C$xChemotherapy. 615 0$aAntiviral agents. 676 $a616.362306 702 $aOmata$b Masao 702 $aKanda$b Tatsuo 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910827838803321 996 $aEmerging therapeutic options for hepatitis C$94007384 997 $aUNINA